RIPK2 and neoplasm: Our analysis demonstrated that RIPK2 upregulation correlated with signature genes of tumor immunity, clinical features of metastasis, and high histological grade, suggesting that RIPK is a potential oncogene and unfavorable clinical prognosis marker for KIRC.